Income Statement

v3.22.2.2
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Sep. 30, 2022
Sep. 30, 2021
Product sales $ 0 $ 0 $ 4 $ 0
Operating cost and expense        
Cost of product sales 833 1,670 3,026 5,417
Research and development cost 490 273 1,561 738
General and administrative expense 2,611 2,681 7,615 7,109
Total operating expense 3,934 4,624 12,202 13,264
Loss from operations (3,934) (4,624) (12,198) (13,264)
Other income and (expense)        
Insurance proceeds net of related expenses 0 4,344 0 4,792
PPP loan forgiveness 0 0 0 332
Gain (loss) on disposal of property and equipment 5 (1,411) 595 (5,665)
Interest expense (9) (5) (22) (15)
Interest and other income 53 310 166 334
Total other income (expense), net 49 3,238 739 (222)
Loss before income tax expense (3,885) (1,386) (11,459) (13,486)
Income tax expense 0 0 (2) (2)
Net loss $ (3,885) $ (1,386) $ (11,461) $ (13,488)
Weighted average shares outstanding, basic and diluted (in shares) 77,402,763 69,609,070 74,871,423 68,223,115
Basic and diluted net loss per share (in dollars per share) $ (0.05) $ (0.02) $ (0.15) $ (0.20)

Source